Ramelteon,a melatonin receptor agonist with both high affinity for MT1 and MT2 receptors,was approved by FDA for the treatment of insomnia characterized by
Nowadays,the development of new anti-HBV agentsis focused on discovering diverse compounds with either novel structures or a new mechanism of action.Non-nuc